{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:57:04Z","timestamp":1775062624054,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1993,10,1]],"date-time":"1993-10-01T00:00:00Z","timestamp":749433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[1993,10]]},"DOI":"10.1007\/bf00966691","type":"journal-article","created":{"date-parts":[[2005,1,8]],"date-time":"2005-01-08T22:59:11Z","timestamp":1105225151000},"page":"1101-1106","source":"Crossref","is-referenced-by-count":21,"title":["Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas"],"prefix":"10.1007","volume":"18","author":[{"given":"Fulvio","family":"Marzatico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Caf\ufffd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Taborelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Benzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl.","key":"CR1","first-page":"89","volume":"19","author":"G. Cohen","year":"1983","unstructured":"Cohen, G. 1983. The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. J. Neural. Transm. (Suppl.) 19:89?103.","journal-title":"J. Neural. Transm."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/B978-0-12-642760-8.50020-X","volume-title":"Oxidative stress","author":"G. Cohen","year":"1985","unstructured":"Cohen, G. 1985. Oxidative stress in the nervous system. Pages 383?402, in Sies, H. (ed.), Oxidative stress, Academic Press, London."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0304-3940(86)90320-4","volume":"67","author":"T. L. Perry","year":"1986","unstructured":"Perry, T. L., and Yong, V. W. 1986. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67:269?214.","journal-title":"Neurosci. Lett."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","volume":"52","author":"D. T. Dexter","year":"1989","unstructured":"Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., and Marsden, C. D. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:381?389.","journal-title":"J. Neurochem."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"R. S. Burns","year":"1983","unstructured":"Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., and Kopin, I. J. 1983. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars-compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. U.S.A. 80:4546?4550.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(84)90521-1","volume":"97","author":"H. Hallman","year":"1984","unstructured":"Hallman, H., Olsen, L., and Jonsson, G. 1984. Neurotoxicity of the meperine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse. Eur. J. Pharmacol. 97:133?136.","journal-title":"Eur. J. Pharmacol."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","volume":"224","author":"R. E. Heikkila","year":"1984","unstructured":"Heikkila, R. E., Hess, A., and Duvoisin, R. C. 1984. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224:1451?1453.","journal-title":"Science"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"J. W. Langston","year":"1983","unstructured":"Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. 1983. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979?980.","journal-title":"Science"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","volume":"35","author":"P. A. Ballard","year":"1985","unstructured":"Ballard, P. A., Tetrud, J. W., and Langston, J. W. 1985. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35:949?956.","journal-title":"Neurology"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(85)91278-4","volume":"1","author":"A. Barbeau","year":"1985","unstructured":"Barbeau, A., Roy, M., and Langston, J. W. 1985. Neurological consequence of industrial exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Lancet 1:747.","journal-title":"Lancet"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1016\/0006-2952(88)90674-0","volume":"37","author":"Z. L. Rossetti","year":"1988","unstructured":"Rossetti, Z. L., Sotgiu, A., Sharp, D., and Hadjiconstantinou, M., Neff, N. H. 1988. 1-methyl-4 phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro. Biochem. Pharmacol. 37:4573?4574.","journal-title":"Biochem. Pharmacol."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1471-4159.1981.tb02411.x","volume":"36","author":"T. S. Brannan","year":"1981","unstructured":"Brannan, T. S., Maker, H. S., and Raes, I. P. 1981. Regional distribution of catalase in the adult brain. J. Neurochem. 36:307?309.","journal-title":"J. Neurochem."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1471-4159.1974.tb04293.x","volume":"22","author":"O. DeMarchena","year":"1974","unstructured":"DeMarchena, O., Guarnieri, M., and McKhann, G. 1974. Glutathione peroxidase levels in brain. J. Neurochem. 22:773?776.","journal-title":"J. Neurochem."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","volume":"33","author":"T. L. Perry","year":"1982","unstructured":"Perry, T. L., Godin, D. V., and Hansen, S. 1982. Parkinson's disease: a disorder due to nigral glutathione deficiency. Neurosci. Lett. 33:305?310.","journal-title":"Neurosci. Lett."},{"key":"CR15","first-page":"21","volume":"55","author":"P. Riederer","year":"1988","unstructured":"Riederer, P., Rausch, W. D., Schmidt, B., Kruzik, P., Konradi, C., Danielczyk, S. E., Fischer, M., and Ogris, E. 1988. Biochemical fundamentals of Parkinson's disease. Mt. Sinai J. Med. 55:21?28.","journal-title":"Mt. Sinai J. Med."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cne.902220208","volume":"222","author":"J. Szabo","year":"1984","unstructured":"Szabo, J., and Cowan, W. M. 1984. A stereotaxic atlas of the brain of the Cynomolgus Monkey (Macaca fascicularis). J. Comp. Neurol. 222:265?300.","journal-title":"J. Comp. Neurol."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","volume":"74","author":"P. J. Hissin","year":"1976","unstructured":"Hissin, P. J., and Hilf, R. 1976. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:214?226.","journal-title":"Anal. Biochem."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H. Ohkawa","year":"1979","unstructured":"Ohkawa, H., Ohishi, N., and Yagi, K. 1979. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal. Biochem. 95:351?358.","journal-title":"Anal. Biochem."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"O. H. Lowry","year":"1951","unstructured":"Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265?275.","journal-title":"J. Biol. Chem."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/978-1-4613-2179-8_59","volume-title":"Alzheimer's and Parkinson's diseases","author":"I. J. Kopin","year":"1986","unstructured":"Kopin, I. J., Burns, G. R., Chiueh, C. C., and Markey, S. P. 1986. MPTP-induced parkinsonian syndromes in humans and animals. Pages 519?530, in Fisher, A., Hanin, I., Lachman, C. (eds.), Alzheimer's and Parkinson's diseases. New York, Plenum Press."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0024-3205(85)90062-1","volume":"36","author":"J. N. Johannessen","year":"1985","unstructured":"Johannessen, J. N., Chiueh, C. C., Burns, R. S., and Markey, S. P. 1985. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects. Life Sci. 36:219?224.","journal-title":"Life Sci."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","volume":"292","author":"J. W. Langston","year":"1984","unstructured":"Langston, J. W., Forno, L. S., Rebert, C. S., and Irwin, I. 1984. Selective nigral toxicity after systemic administration of 1-methyl-4 phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res. 292:390?394.","journal-title":"Brain Res."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3171\/jns.1990.72.4.0610","volume":"72","author":"H. Kudo","year":"1990","unstructured":"Kudo, H., Mio, T., Kokunai, T., Tamaki, N., Sumino, K., and Matsumoto, S. 1990. Quantitative analysis of glutathione in human brain tumors. J. Neurosurg. 72:610?615.","journal-title":"J. Neurosurg."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","volume":"120","author":"K. Chiba","year":"1984","unstructured":"Chiba, K., Trevor, A., and Castagnoli, N. 1984. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120:574?578.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/311464a0","volume":"311","author":"S. P. Markey","year":"1984","unstructured":"Markey, S. P., Johannessen, J. N., Chiueh C. C., and Burns, R. S., Herkerkenham, R. S. 1984. Intra-neuronal generation of a pyridinium metabolite may cause drug induced parkinsonism. Nature 311:464?467.","journal-title":"Nature"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1471-4159.1986.tb01768.x","volume":"46","author":"I. Vyas","year":"1986","unstructured":"Vyas, I., Heikkila, R. E., and Nicklas, W. J. 1986. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenyl pyridinium. J. Neurochem. 46:1501?1507.","journal-title":"J. Neurochem."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1515\/bchm2.1982.363.1.599","volume":"363","author":"H. Nohl","year":"1982","unstructured":"Nohl, H., Jordan, W., and Hegner, D. 1982. Mitochondrial formation of OH0 radicals by a ubisemiquinone-dependent reaction. An alternative pathway of the iron-catalyzed Haber-Weiss-cycle. Hope Seyler's Z. Physiol. Chem. 363:599?607.","journal-title":"Hope Seyler's Z. Physiol. Chem."},{"key":"CR28","first-page":"77","volume-title":"Free radicals, aging and degenerative diseases","author":"H. Nohl","year":"1986","unstructured":"Nohl, H. 1986. Oxygen radical release in mitochondria: influence of age. Pages. 77?97, in: Free radicals, aging and degenerative diseases. New York, Alan R. Liss Inc."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0197-4580(92)90109-B","volume":"13","author":"G. Benzi","year":"1992","unstructured":"Benzi, G., Pastoris, O., Marzatico, F., Villa, R. F., Dagani, F., and Curti, D. 1992. The mitochondrial electron transfer alteration as a factor involved in the brain aging. Neurobiol. Aging 13:361?368.","journal-title":"Neurobiol. Aging"},{"key":"CR30","volume-title":"Catecholamines II. Handbook of experimental pharmacology","author":"M. B. H. Youdin","year":"1989","unstructured":"Youdin, M. B. H., Finberg, J., and Tipton, K. F. 1989. Monoamine-oxidases.in Weiner, N., Trendelenburg, U. (eds.), Catecholamines II. Handbook of experimental pharmacology, Berlin, Springer-Verlag."},{"key":"CR31","first-page":"633","volume":"14","author":"D. G. Graham","year":"1978","unstructured":"Graham, D. G., 1978. Oxidative pathways for cathecolamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14:633?634.","journal-title":"Mol. Pharmacol."},{"key":"CR32","first-page":"83","volume":"5","author":"D. G. Graham","year":"1984","unstructured":"Graham, D. G. 1984. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5:83?96.","journal-title":"Neurotoxicology"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-7091-8822-4_14","volume-title":"L-Dopa-substitution der Parkinson-krankheit","author":"P. Riederer","year":"1985","unstructured":"Riederer, P., Sofic, E., Ransch, W. D., Kruzik, P., and Youdim, M. B. H. 1985. Dopaminforshung heute und morgen: L-Dopa in der zukunft. Pages 127?144, in Riederer, P., Umek, H. (eds.), L-Dopa-substitution der Parkinson-krankheit. New York, Wien, Springer-Verlag."},{"key":"CR34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0304-3940(86)90012-1","volume":"63","author":"V. W. Yong","year":"1986","unstructured":"Yong, V. W., Perry, T. L., and Krisman, A. A. 1986. Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6 tetrahydropyridine is prevented by antioxidant pretreatment. Neurosci. Lett. 63:56?60.","journal-title":"Neurosci. Lett."},{"key":"CR35","first-page":"1470","volume":"12","author":"T. H. McNeill","year":"1986","unstructured":"McNeill, T. H., Koek, L. L., Haycock, J. W., and Gash, D. M. 1986. Glutathione reduction mimics MPTP neurotoxicity and age correlated changes in dopamine neurons in substantia nigra of the C57BL\/6NNia mouse. Soc. Neurosci. Abst. 12:1470.","journal-title":"Soc. Neurosci. Abst."},{"key":"CR36","first-page":"44","volume":"39","author":"G. Benzi","year":"1984","unstructured":"Benzi, G., Villa, R. F., Dossena, M., Vercesi, L., Gorini, A., and Pastoris, O. 1984. Cerebral and cerebellar metabolic changes induced by drugs during the recovery period after profound hypoglycemia. II Farmaco 39:44?56.","journal-title":"II Farmaco"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0197-4580(88)80083-6","volume":"9","author":"G. Benzi","year":"1988","unstructured":"Benzi, G., Pastoris, O., Marzatico, F., and Villa, R. F. 1988. Influence of aging and drug treatment on the cerebral glutathione system. Neurobiol. Aging 9:371?375.","journal-title":"Neurobiol. Aging"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF01268883","volume":"13","author":"G. Benzi","year":"1988","unstructured":"Benzi, G., Pastoris, O., and Villa, R. F. 1988. Changes induced by aging and drug treatment on cerebral enzymatic antioxidant system. Neurochem. Res. 13:467?478.","journal-title":"Neurochem. Res."},{"key":"CR39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00964863","volume":"14","author":"G. Benzi","year":"1989","unstructured":"Benzi, G., Pastoris, O., Marzatico, F., Villa, R. F. 1989. Age-related effect induced by oxidative stress on the cerebral glutathione system. Neurochem. Res. 14:473?481.","journal-title":"Neurochem. Res."}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00966691.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00966691\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00966691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T20:13:51Z","timestamp":1625343231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00966691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1993,10]]}},"alternative-id":["BF00966691"],"URL":"https:\/\/doi.org\/10.1007\/bf00966691","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,10]]}}}